Core Viewpoint - Cencora (COR) is expected to report quarterly earnings of $4.08 per share, reflecting a 7.4% increase year-over-year, with revenues projected at $74.82 billion, indicating a 9.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.2% in the last 30 days, showcasing analysts' reassessment of their initial projections [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Revenue- Total International Healthcare Solutions' at $7.36 billion, a year-over-year increase of 3.3% [5]. - The consensus for 'Revenue- Total U.S. Healthcare Solutions' is $67.56 billion, reflecting a 10.2% increase from the same quarter last year [5]. - 'Revenue- International Healthcare Solutions- Alliance Healthcare' is projected to reach $5.98 billion, indicating a 3.9% year-over-year change [6]. - 'Revenue- U.S. Healthcare Solutions- Animal Health' is expected to be $1.49 billion, suggesting a 14.1% increase year-over-year [6]. - 'Revenue- U.S. Healthcare Solutions- Human Health' is forecasted at $65.56 billion, reflecting a 9.3% year-over-year growth [6]. - 'Revenue- International Healthcare Solutions- Other Healthcare Solutions' is estimated at $1.42 billion, indicating a 3.8% increase from the previous year [7]. Operating Income Estimates - Analysts project 'Operating income- Non-GAAP- International Healthcare Solutions' to be $182.43 million, down from $192.72 million reported in the same quarter last year [7]. - 'Operating income- Non-GAAP- U.S. Healthcare Solutions' is expected to reach $926.36 million, compared to $841.06 million from the previous year [8]. Stock Performance - Over the past month, Cencora shares have returned +0.4%, outperforming the Zacks S&P 500 composite, which recorded a -0.5% change [8].